Crossmark

Die IDH-Mutation als Target in der Krebstherapie

Crossref DOI link: https://doi.org/10.1007/s15004-025-0870-8

Published Online: 2025-02-20

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2025-02-01

Version of Record valid from 2025-02-01
More Information

Article History

First Online: 20 February 2025

Free to read: This content has been made available to all.